Impact of prior antiandrogen exposure on clinical outcomes in patients (pts) receiving abiraterone acetate (AA): Results from a randomized study (COU-AA-301) in metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel (D) Meeting Abstract
| Authors: | Bellmunt, J.; Yu, M. K.; Kheoh, T.; Taplin, M. E.; Davis, I. D.; Schnjvers, D.; Protheroe, A.; Molina, A.; de Bono, J. S.; Scher, H. I. |
| Abstract Title: | Impact of prior antiandrogen exposure on clinical outcomes in patients (pts) receiving abiraterone acetate (AA): Results from a randomized study (COU-AA-301) in metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel (D) |
| Meeting Title: | 17th European Cancer Conference (ECCO 17) |
| Journal Title: | European Journal of Cancer |
| Volume: | 49 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2013 Sep 27-Oct 1 |
| Meeting Location: | Amsterdam, Netherlands |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-09-01 |
| Start Page: | S695 |
| Language: | English |
| ACCESSION: | WOS:000326843604259 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(13)70064-9 |
| Notes: | Meeting Abstract: 2897 -- 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS -- Source: Wos |
